The analyst firm set a price target for 4000 expecting SCYX to rise to within 12 months a possible. Q1 GAAP EPS of -023 beats by 035.
Get the latest news and real-time alerts from SCYNEXIS Inc.
Scyx stock news. JERSEY CITY NJ Dec. 22 2020 GLOBE NEWSWIRE -- SCYNEXIS Inc. Cash and cash equivalents totaled 92M.
SCYNEXIS NASDAQ Updated May 12 2021 1032 PM. SCYX stock quote history news and other vital information to help you with your stock trading and investing. Davidson CO GSA Capital Partners LLP and HighMark Wealth Management LLC.
View real-time stock prices and stock quotes for a full financial overview. Shweta Agarwal SA News Editor 1 Comment SCYNEXIS NASDAQ. May 17 2021 900 AM ET SCYNEXIS Inc.
SCYX stock at Seeking Alpha. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Real time SCYNEXIS SCYX stock price quote stock graph news analysis.
Find the latest news headlines from SCYNEXIS Inc. A high-level overview of SCYNEXIS Inc. Stock news by MarketWatch.
SCYX today announced the closing of its previously announced underwritten public offering of common stock. JERSEY CITY NJ April 20 2021 GLOBE NEWSWIRE -- SCYNEXIS Inc. SCYX Complete SCYNEXIS Inc.
Company insiders that have bought SCYNEXIS stock in the last two years include Brian Philippe Tinmouth Eric Francois Marco Taglietti and Scott Sukenick. Get the latest SCYNEXIS stock price and detailed information including SCYX news historical charts and realtime prices. SCYX was reported by Aegis Capital on 2021-04-12.
SCYX 701 003 043. SCYNEXIS Announces Launch of 50 Million Public Offering of Common Stock and Warrants GlobeNewswire 421 PM ET 12162020 SCYNEXIS Announces Advancement of Ibrexafungerps Intravenous Formulation to Clinical Stage and Provides Further Updates on its Clinical Studies in Patients with Life-Threatening Fungal Infections. The latest price target for SCYNEXIS NASDAQ.
Scynexis SCYX Reports Q3 Loss Lags Revenue Estimates by Zacks Equity Research Published on November 122019 Scynexis SCYX delivered earnings and revenue surprises of 455 and -10000. On May 10 2021 SCYNEXIS granted stock options to three new employees to purchase an aggregate of 15000 shares of SCYNEXIS common stock at a per share exercise price of 650 the closing. Find the latest SCYNEXIS Inc.
SCYX a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections today announced that two data sets from the Companys Phase 3 VANISH Program evaluating ibrexafungerp as a treatment for vulvovaginal. SCYX stock was acquired by a variety of institutional investors in the last quarter including BlackRock Inc DA.
